• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    More On ESALY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Eisai Co., Ltd. (ESALY)

    -Other OTC
    62.24 Down 2.07(3.21%) Feb 12, 2:41PM EST
    Prev Close:64.31
    Open:61.59
    Bid:N/A
    Ask:N/A
    1y Target Est:97.39
    Beta:-0.267194
    Next Earnings Date:N/A
    Day's Range:61.59 - 62.24
    52wk Range:51.88 - 80.41
    Volume:844
    Avg Vol (3m):2,684
    Market Cap:17.79B
    P/E (ttm):45.94
    EPS (ttm):1.36
    Div & Yield:1.13 (1.76%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):66.22
    P/S (ttm):3.68
    Ex-Dividend Date:25-Sep-15

    Analysts

    Annual EPS Est (Mar-16) :1.13
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):21.89

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Eisai Co., Ltd. manufactures and sells pharmaceutical products worldwide. The company offers oncology-related products, such as Halaven, an anticancer agent; Aloxi, an antiemetic agent; and Fragmin, an injectable anticlotting agent, as well as Sym... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback